(Q54021562)

23 May 2018

editorial

0 references

review article

1 reference

title

Critical issues of HIV treatment in the era of highly active antiretroviral therapy. (English)

1 reference

23 May 2018

main subject

anti-retroviral agent

0 references

author name string

Battegay M

series ordinal

1

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 February 2001

1 reference

23 May 2018

Expert Opinion on Investigational Drugs

published in

1 reference

23 May 2018

volume

10

1 reference

23 May 2018

issue

2

1 reference

23 May 2018

page(s)

175-183

1 reference

23 May 2018

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

Time to hit HIV, early and hard.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

Immune restoration with antiretroviral therapies: implications for clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

Medical treatment of opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

21 January 2018

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.175

10.1517/13543784.10.2.175

21 January 2018

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

11178335

1 reference

23 May 2018